Gene‐environment interaction in type 2 diabetes in Korean cohorts: Interaction of a type 2 diabetes polygenic risk score with triglyceride and cholesterol on fasting glucose levels

• Published in: Genetic epidemiology 2022-07, Vol.46 (5-6), p.285-302
• Main Authors: Lim, Ji Eun, Kang, Ji‐one, Ha, Tae‐Woong, Jung, Hae‐Un, Kim, Dong Jun, Baek, Eun Ju, Kim, Han Kyul, Chung, Ju Yeon, Rhee, Sang Youl, Kim, Mi Kyung, Kim, Yeon‐Jung, Park, Taesung, Oh, Bermseok
• Format: Article
• Language: English
• Subjects: Cholesterol; Diabetes; Diabetes mellitus (non-insulin dependent); Environmental factors; Fasting; fasting glucose level; Genetic factors; gene‐environment interactions; Genomes; genome‐wide association study; Glucose; Laboratory testing; polygenic risk score; Risk factors; Single-nucleotide polymorphism; type 2 diabetes
• ISSN: 0741-0395; 1098-2272
• DOI: 10.1002/gepi.22454

Type 2 diabetes (T2D) is caused by genetic and environmental factors as well as gene‐environment interactions. However, these interactions have not been systematically investigated. We analyzed these interactions for T2D and fasting glucose levels in three Korean cohorts, HEXA, KARE, and CAVAS, using the baseline data with a multiple regression model. Two polygenic risk scores for T2D (PRST2D) and fasting glucose (PRSFG) were calculated using 488 and 82 single nucleotide polymorphisms (SNP) for T2D and fasting glucose, respectively, which were extracted from large‐scaled genome‐wide association studies with multiethnic data. Both lifestyle risk factors and T2D‐related biochemical measurements were assessed. The effect of interactions between PRST2D‐triglyceride (TG) and PRST2D‐total cholesterol (TC) on fasting glucose levels was observed as follows: β ± SE = 0.0005 ± 0.0001, p = 1.06 × 10−19 in HEXA, β ± SE = 0.0008 ± 0.0001, p = 2.08 × 10−8 in KARE for TG; β ± SE = 0.0006 ± 0.0001, p = 2.00 × 10−6 in HEXA, β ± SE = 0.0020 ± 0.0004, p = 2.11 × 10−6 in KARE, β ± SE = 0.0007 ± 0.0004, p = 0.045 in CAVAS for TC. PRST2D‐based classification of the participants into four groups showed that the fasting glucose levels in groups with higher PRST2D were more adversely affected by both the TG and TC. In conclusion, blood TG and TC levels may affect the fasting glucose level through interaction with T2D genetic factors, suggesting the importance of consideration of gene‐environment interaction in the preventive medicine of T2D.